Borosil Renewables Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: April 24, 2025, 9:54 pm

Competitors of Borosil Renewables Ltd

All Competitor Stocks of Borosil Renewables Ltd

Quarterly Result

Last Updated: March 3, 2025, 5:10 pm

Below is a detailed analysis of the quarterly data for Borosil Renewables Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

• For Sales, as of Dec 2024, the value is 361.00 Cr.. The value appears to be declining and may need further review. It has decreased from 373.00 Cr. (Sep 2024) to 361.00 Cr., marking a decrease of 12.00 Cr..
• For Expenses, as of Dec 2024, the value is 372.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 344.00 Cr. (Sep 2024) to 372.00 Cr., marking an increase of 28.00 Cr..
• For Operating Profit, as of Dec 2024, the value is -10.00 Cr.. The value appears to be declining and may need further review. It has decreased from 29.00 Cr. (Sep 2024) to -10.00 Cr., marking a decrease of 39.00 Cr..
• For OPM %, as of Dec 2024, the value is -3.00%. The value appears to be declining and may need further review. It has decreased from 8.00% (Sep 2024) to -3.00%, marking a decrease of 11.00%.
• For Other Income, as of Dec 2024, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from 5.00 Cr. (Sep 2024) to 15.00 Cr., marking an increase of 10.00 Cr..
• For Interest, as of Dec 2024, the value is 5.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 10.00 Cr. (Sep 2024) to 5.00 Cr., marking a decrease of 5.00 Cr..
• For Depreciation, as of Dec 2024, the value is 32.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 33.00 Cr. (Sep 2024) to 32.00 Cr., marking a decrease of 1.00 Cr..
• For Profit before tax, as of Dec 2024, the value is -32.00 Cr.. The value appears to be declining and may need further review. It has decreased from -8.00 Cr. (Sep 2024) to -32.00 Cr., marking a decrease of 24.00 Cr..
• For Tax %, as of Dec 2024, the value is -6.00%. The value appears to be improving (decreasing) as expected. It has decreased from 58.00% (Sep 2024) to -6.00%, marking a decrease of 64.00%.
• For Net Profit, as of Dec 2024, the value is -30.00 Cr.. The value appears to be declining and may need further review. It has decreased from -13.00 Cr. (Sep 2024) to -30.00 Cr., marking a decrease of 17.00 Cr..
• For EPS in Rs, as of Dec 2024, the value is -2.05. The value appears to be declining and may need further review. It has decreased from -0.75 (Sep 2024) to -2.05, marking a decrease of 1.30.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 4:39 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: November 15, 2024, 1:34 am

Below is a detailed analysis of the balance sheet data for Borosil Renewables Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2024, the value is ₹13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 13.00 Cr..
• For Reserves, as of Sep 2024, the value is ₹839.00 Cr.. The value appears to be declining and may need further review. It has decreased from 860.00 Cr. (Mar 2024) to ₹839.00 Cr., marking a decrease of 21.00 Cr..
• For Borrowings, as of Sep 2024, the value is ₹557.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 576.00 Cr. (Mar 2024) to ₹557.00 Cr., marking a decrease of 19.00 Cr..
• For Other Liabilities, as of Sep 2024, the value is ₹243.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 235.00 Cr. (Mar 2024) to ₹243.00 Cr., marking an increase of 8.00 Cr..
• For Total Liabilities, as of Sep 2024, the value is ₹1,652.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,684.00 Cr. (Mar 2024) to ₹1,652.00 Cr., marking a decrease of 32.00 Cr..
• For Fixed Assets, as of Sep 2024, the value is ₹877.00 Cr.. The value appears to be declining and may need further review. It has decreased from 928.00 Cr. (Mar 2024) to ₹877.00 Cr., marking a decrease of 51.00 Cr..
• For CWIP, as of Sep 2024, the value is ₹130.00 Cr.. The value appears strong and on an upward trend. It has increased from 126.00 Cr. (Mar 2024) to ₹130.00 Cr., marking an increase of 4.00 Cr..
• For Investments, as of Sep 2024, the value is ₹12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 12.00 Cr..
• For Other Assets, as of Sep 2024, the value is ₹633.00 Cr.. The value appears strong and on an upward trend. It has increased from 618.00 Cr. (Mar 2024) to ₹633.00 Cr., marking an increase of 15.00 Cr..
• For Total Assets, as of Sep 2024, the value is ₹1,652.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,684.00 Cr. (Mar 2024) to ₹1,652.00 Cr., marking a decrease of 32.00 Cr..

Notably, the Reserves (839.00 Cr.) exceed the Borrowings (557.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Borosil Renewables Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 24, the value is -3.59. This value is below the healthy minimum of 5. It has decreased from 5.34 (Mar 23) to -3.59, marking a decrease of 8.93.
• For Diluted EPS (Rs.), as of Mar 24, the value is -3.59. This value is below the healthy minimum of 5. It has decreased from 5.34 (Mar 23) to -3.59, marking a decrease of 8.93.
• For Cash EPS (Rs.), as of Mar 24, the value is 6.17. This value is within the healthy range. It has decreased from 9.55 (Mar 23) to 6.17, marking a decrease of 3.38.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 68.39. It has decreased from 72.23 (Mar 23) to 68.39, marking a decrease of 3.84.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 68.39. It has decreased from 72.23 (Mar 23) to 68.39, marking a decrease of 3.84.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 104.90. It has increased from 68.51 (Mar 23) to 104.90, marking an increase of 36.39.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 5.73. This value is within the healthy range. It has decreased from 12.48 (Mar 23) to 5.73, marking a decrease of 6.75.
• For PBIT / Share (Rs.), as of Mar 24, the value is -4.36. This value is below the healthy minimum of 0. It has decreased from 8.34 (Mar 23) to -4.36, marking a decrease of 12.70.
• For PBT / Share (Rs.), as of Mar 24, the value is -4.11. This value is below the healthy minimum of 0. It has decreased from 7.74 (Mar 23) to -4.11, marking a decrease of 11.85.
• For Net Profit / Share (Rs.), as of Mar 24, the value is -3.92. This value is below the healthy minimum of 2. It has decreased from 5.41 (Mar 23) to -3.92, marking a decrease of 9.33.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is -3.59. This value is below the healthy minimum of 2. It has decreased from 5.34 (Mar 23) to -3.59, marking a decrease of 8.93.
• For PBDIT Margin (%), as of Mar 24, the value is 5.46. This value is below the healthy minimum of 10. It has decreased from 18.21 (Mar 23) to 5.46, marking a decrease of 12.75.
• For PBIT Margin (%), as of Mar 24, the value is -4.15. This value is below the healthy minimum of 10. It has decreased from 12.17 (Mar 23) to -4.15, marking a decrease of 16.32.
• For PBT Margin (%), as of Mar 24, the value is -3.91. This value is below the healthy minimum of 10. It has decreased from 11.30 (Mar 23) to -3.91, marking a decrease of 15.21.
• For Net Profit Margin (%), as of Mar 24, the value is -3.73. This value is below the healthy minimum of 5. It has decreased from 7.90 (Mar 23) to -3.73, marking a decrease of 11.63.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is -3.42. This value is below the healthy minimum of 8. It has decreased from 7.78 (Mar 23) to -3.42, marking a decrease of 11.20.
• For Return on Networth / Equity (%), as of Mar 24, the value is -5.37. This value is below the healthy minimum of 15. It has decreased from 7.57 (Mar 23) to -5.37, marking a decrease of 12.94.
• For Return on Capital Employeed (%), as of Mar 24, the value is -4.18. This value is below the healthy minimum of 10. It has decreased from 8.31 (Mar 23) to -4.18, marking a decrease of 12.49.
• For Return On Assets (%), as of Mar 24, the value is -2.78. This value is below the healthy minimum of 5. It has decreased from 4.26 (Mar 23) to -2.78, marking a decrease of 7.04.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.48. This value is within the healthy range. It has increased from 0.34 (Mar 23) to 0.48, marking an increase of 0.14.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.65. This value is within the healthy range. It has increased from 0.45 (Mar 23) to 0.65, marking an increase of 0.20.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.82. It has increased from 0.00 (Mar 23) to 0.82, marking an increase of 0.82.
• For Current Ratio (X), as of Mar 24, the value is 1.85. This value is within the healthy range. It has increased from 1.73 (Mar 23) to 1.85, marking an increase of 0.12.
• For Quick Ratio (X), as of Mar 24, the value is 1.09. This value is within the healthy range. It has increased from 0.90 (Mar 23) to 1.09, marking an increase of 0.19.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.38. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 23) to 1.38, marking an increase of 1.38.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 2.56. This value is below the healthy minimum of 3. It has decreased from 20.90 (Mar 23) to 2.56, marking a decrease of 18.34.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is -1.86. This value is below the healthy minimum of 3. It has decreased from 10.07 (Mar 23) to -1.86, marking a decrease of 11.93.
• For Enterprise Value (Cr.), as of Mar 24, the value is 6,927.23. It has increased from 5,683.43 (Mar 23) to 6,927.23, marking an increase of 1,243.80.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 5.06. This value exceeds the healthy maximum of 3. It has decreased from 6.36 (Mar 23) to 5.06, marking a decrease of 1.30.
• For EV / EBITDA (X), as of Mar 24, the value is 92.55. This value exceeds the healthy maximum of 15. It has increased from 34.90 (Mar 23) to 92.55, marking an increase of 57.65.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 4.75. This value exceeds the healthy maximum of 3. It has decreased from 6.01 (Mar 23) to 4.75, marking a decrease of 1.26.
• For Retention Ratios (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Price / BV (X), as of Mar 24, the value is 7.45. This value exceeds the healthy maximum of 3. It has increased from 5.85 (Mar 23) to 7.45, marking an increase of 1.60.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 4.75. This value exceeds the healthy maximum of 3. It has decreased from 6.01 (Mar 23) to 4.75, marking a decrease of 1.26.
• For EarningsYield, as of Mar 24, the value is -0.01. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 23) to -0.01, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness